MedTrace Logo

Azithromycin Before Induction

NCT06543290 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-09-12

No results posted yet for this study

Summary

This is a double blinded randomized control trial involving administration of 2 grams prophylactic azithromycin in third trimester patients undergoing induction of labor at our institution to demonstrate reduction in maternal and neonatal infection.

Conditions

Interventions

DRUG

Azithromycin Pill

Azithromycin 2 grams to be administered prior to start of induction for those randomized to intervention group

DRUG

Placebo

4 magnesium oxide tablets prior to the start of induction for those randomized to placebo

Sponsors & Collaborators

  • Arrowhead Regional Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-07
Primary Completion
2026-08-07
Completion
2026-08-07
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06543290 on ClinicalTrials.gov